PT-141, also known as bremelanotide, is a synthetic cyclic peptide studied for its interaction with melanocortin receptors. Research has examined its activity at receptor subtypes involved in nervous system signalling, including MC3R and MC4R.
In simple terms: researchers study PT-141 to understand how melanocortin signalling influences neural pathways associated with sexual response and behaviour.
This product is supplied for controlled laboratory research. Refer to the individual listing and batch documentation for the vial strength and product specifications.
Product Details
| Component | Details |
|---|---|
| Compound | PT-141 |
| Also known as | Bremelanotide |
| Research category | Melanocortin receptor and neural signalling research |
| Vial strength | As stated on the selected product listing |
What Is PT-141 Studied For?
Preclinical and laboratory research only
Melanocortin receptors: Researchers investigate how PT-141 binds to and activates melanocortin receptor subtypes, including MC3R and MC4R.
Neural signalling: Experimental studies examine melanocortin pathways in the central nervous system and their relationship with physiological and behavioural responses.
Sexual response and behaviour: Animal models have been used to investigate PT-141’s influence on pathways associated with sexual arousal and behaviour.
Receptor activity: Laboratory research examines PT-141’s binding affinity and activity across melanocortin receptor subtypes. Results from those studies do not establish the effects of this research-use vial.
Research Use Notice
FOR RESEARCH PURPOSES ONLY. This Riptide product is intended for laboratory research and is not offered for human or veterinary use. It is not intended for therapeutic or diagnostic purposes. Handle and store according to applicable laboratory procedures and the product’s batch documentation.
